These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35609780)

  • 1. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.
    Cuozzo A; Iorio-Siciliano V; Vaia E; Mauriello L; Blasi A; Ramaglia L
    J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):616-621. PubMed ID: 35609780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
    Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Moreno-Rabié C; Fontenele RC; Oliveira-Santos N; Nogueira-Reis F; Van den Wyngaert T; Jacobs R
    Osteoporos Int; 2024 Aug; 35(8):1431-1440. PubMed ID: 38767743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.
    Hasegawa T; Hayashida S; Kondo E; Takeda Y; Miyamoto H; Kawaoka Y; Ueda N; Iwata E; Nakahara H; Kobayashi M; Soutome S; Yamada SI; Tojyo I; Kojima Y; Umeda M; Fujita S; Kurita H; Shibuya Y; Kirita T; Komori T;
    Osteoporos Int; 2019 Jan; 30(1):231-239. PubMed ID: 30406309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tooth extraction in osteoporotic patients taking oral bisphosphonates.
    Mozzati M; Arata V; Gallesio G
    Osteoporos Int; 2013 May; 24(5):1707-12. PubMed ID: 23288026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.
    Hadad H; Matheus HR; Pai SI; Souza FA; Guastaldi FPS
    Arch Oral Biol; 2024 Mar; 159():105875. PubMed ID: 38160519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: A national cohort-based study.
    Kwoen MJ; Park JH; Kim KS; Lee JR; Kim JW; Lee H; Lee HJ
    J Periodontol; 2023 Jan; 94(1):98-107. PubMed ID: 35856336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
    Moreno-Rabié C; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; Gielen E; Van den Wyngaert T; Jacobs R
    Oral Dis; 2024 Apr; 30(3):1632-1642. PubMed ID: 36620873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients-A systematic review.
    Schwech N; Nilsson J; Gabre P
    Clin Exp Dent Res; 2023 Feb; 9(1):55-65. PubMed ID: 36464958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis.
    Campisi G; Mauceri R; Bertoldo F; Fusco V; Bedogni A
    Head Face Med; 2021 Jul; 17(1):25. PubMed ID: 34243807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Shudo A; Kishimoto H; Takaoka K; Noguchi K
    Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report.
    Penoni DC; Canellas JVS; Silami MANC; Sader F; Pimentel GS; Leão ATT
    Arch Endocrinol Metab; 2023 May; 67(4):e000612. PubMed ID: 37252700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients.
    Coropciuc R; Coopman R; Garip M; Gielen E; Politis C; Van den Wyngaert T; Beuselinck B
    Bone; 2023 May; 170():116722. PubMed ID: 36858337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Incidence Rate, and Risk Factors of Medication-Related Osteonecrosis of the Jaw in Patients With Osteoporosis and Cancer: A Nationwide Population-Based Study in Japan.
    Ishimaru M; Ono S; Morita K; Matsui H; Hagiwara Y; Yasunaga H
    J Oral Maxillofac Surg; 2022 Apr; 80(4):714-727. PubMed ID: 35033505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.